HTDS completes Quarterly Reports

NewsGuard 100/100 Score

Hard to Treat Diseases, Inc. (HTDS; http://www.htdsmedical.com) and the company's IR representative Mina Mar Marketing Group (http://www.minamargroup.net/) announce, that the company completed its Quarterly Reports.

Hard to Treat Diseases, Inc. publishes this Quarterly Report to serve the company's followers, investors and the public as a guidance through the past events and possible outcomes of these events in the upcoming quarter(s). The goal of this Quarterly Report is to inform about the activities and business achievements accomplished by Hard to Treat Diseases, Inc. during the January 1 - March 30, 2010 period. This report assembles and summarizes all developments realized during this time period.

The report is now available on the company's IR's website (http://www.minamargroup.net/) and on Pink Sheets under Filings.

In other news and events, There appears to be some confussion about HTDS Melem Secrets web site with some of HTDS critics trying to confuse new or novice shareholders. The official web site for HTDS Melem Secrets is www.melemsecrets.com The company can not comment on any other web sites that sell similar producs as Melem Secrets. The company has posted its financial reports on its web site www.htds/medical.com The company will shortly subscribe to Pink Sheets and begin filing on Pink Sheets.

The company reminds its shareholders and followers to monitor PinkSheets.com Filing section and also our IR company web site section "PRESS RELEASES AND FILINGS" TAB http://www.minamargroup.net/ for non newsworthy corporate updates.

For any matters relating to retail investor queries or to send the company or its IR a message please click on the "INVESTOR SUPPORT" TAB, or the direct link http://www.minamargroup.net/helpdesk. In this regard, Mina Mar Group works diligently to answer and address all the pressing issues regarding its clients to the shareholders' satisfaction. MMG is in constant contact with the companies, addressing, obtaining and processing all inquiries. MMG is often one of the advisors or IR companies utilized by the issuer. Depending on the location of the issuer and management's availability, it may take up to several days to address any pressing issues. In a normal course of business and a pending transaction, the issuer may opt to remain silent in order not to lose advantage to a competitor. MMG is mindful that sometimes shareholders want answers immediately, which for the above reasons cannot be fulfilled on a timely basis.

Don't be a victim. Report a stock basher to authorities. The company is mindful that short sellers, the company competitors and stock bashers stalk small cap Pink Sheets listed companies with hidden agendas. Visit http://www.stockbasher.com/ and find out what criminal and civil actions the US authorities are taking against web sites like investorshub.com and other posters, and the remedies available to you as an individual investor. MMG encourages the readers to visit this investorshub.com blog and similar "investors" web sites with an open mind. Discover for yourself why and how USA based small businesses and the backbone of the economy suffer. Stay informed and do not allow entrepreneurs dreams, innovations, and their access to capital to be thwarted as "scalpers" and day traders vigorously day in and day out try to exploit and extinguish US innovation and progress for quick profits.

Filings for this event are currently being reviewed and will be filed with Pink Sheets and Client Support section in due course. To be included in company's email database for press releases, industry updates, and non-weekly activity in the company that may or may not be news released, please subscribe or opt in mailer at http://www.minamargroup.com/updates.

Source:

Hard to Treat Diseases

Posted in:

Tags: ,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.